Clinical Trial Update: Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized trial evaluating finerenone and empagliflozin to delay renal function decline after radical nephrectomy in high-risk chronic ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Cell Carcinoma

Drugs mentioned

• Jardiance (empagliflozin)
• Kerendia (finerenone)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC) | Phase 2 | Status: TERMINATED